Skip to content

Fatigue may be misdiagnosed as depression during anti-HCV therapy in HIV coinfected

Infection and cancer still biggest killers of HIV-positive patients, US study shows

Non-invasive probe can stage liver disease in HIV / hepatitis C co-infected patients

Viral hepatitis in low and middle-income settings

HIV and hepatitis in non-injecting drug users

Increase ribavirin dose for better HCV treatment response in coinfected individuals, experts argue

HAART reduces liver-related death risk, but hepatitis C infection increases risk, Italian study finds

HIV/HCV coinfected patients have poorer immunologic response to HIV treatment

Immune reconstitution syndrome risk highest in those commencing HIV therapy with advanced HIV disease